Histogenics Corporation Announces First Quarter 2018 Financial and Operating Results
10 mai 2018 06h30 HE
|
Histogenics Corporation
‒ Top-line Superiority Data from NeoCart® Phase 3 Clinical Trial and Potential Biologics License Application Submission on Track for Third Quarter of 2018 ‒‒ Initiation of Phase 3 Clinical Trial in...
Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018
26 avr. 2018 08h30 HE
|
Histogenics Corporation
WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and...
Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors
18 avr. 2018 08h30 HE
|
Histogenics Corporation
WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset...
Histogenics Corporation to Present at Upcoming Investor Conferences
28 mars 2018 08h30 HE
|
Histogenics Corporation
WALTHAM, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation to Present at Needham & Company’s 17th Annual Healthcare Conference
19 mars 2018 08h30 HE
|
Histogenics Corporation
WALTHAM, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017
15 mars 2018 06h00 HE
|
Histogenics Corporation
NeoCart® Top-line Phase 3 Clinical Trial Data and Potential Biologics License Application Filing Remain on Track for Third Quarter of 2018 NeoCart Licensing Agreement with MEDINET Co. Ltd. Provides...
Histogenics to Showcase NeoCart® at American Academy of Orthopedic Surgeons and Orthopedic Research Society 2018 Annual Meetings
02 mars 2018 08h30 HE
|
Histogenics Corporation
WALTHAM, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation to Report 2017 Financial Results on March 15, 2018
01 mars 2018 08h30 HE
|
Histogenics Corporation
WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and...
Histogenics Corporation to Present at Upcoming Investor Conferences
20 févr. 2018 08h30 HE
|
Histogenics Corporation
WALTHAM, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
25 janv. 2018 16h05 HE
|
Histogenics Corporation
WALTHAM, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies, today announced the closing of its...